416 related articles for article (PubMed ID: 11169524)
1. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
2. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
3. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
5. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
6. Parallel fluctuation of anti-desmoglein 3 and anti-BP180 autoantibody titres in a patient with bullous pemphigoid.
Takahashi H; Anzai H; Suzuki Y; Tanikawa A; Amagai M; Nishikawa T
Clin Exp Dermatol; 2004 Nov; 29(6):608-11. PubMed ID: 15550133
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
9. An animal model of bullous pemphigoid: what can it teach us?
Giudice GJ; Liu Z; Diaz LA
Proc Assoc Am Physicians; 1995 Jul; 107(2):237-41. PubMed ID: 8624858
[TBL] [Abstract][Full Text] [Related]
10. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
11. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
12. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.
Nagasaka T; Nishifuji K; Ota T; Whittock NV; Amagai M
J Clin Invest; 2004 Nov; 114(10):1484-92. PubMed ID: 15545999
[TBL] [Abstract][Full Text] [Related]
13. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
Andreadis D; Lorenzini G; Drakoulakos D; Belazi M; Mihailidou E; Velkos G; Mourellou-Tsatsou O; Antoniades D
Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
[TBL] [Abstract][Full Text] [Related]
14. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.
Li N; Zhao M; Hilario-Vargas J; Prisayanh P; Warren S; Diaz LA; Roopenian DC; Liu Z
J Clin Invest; 2005 Dec; 115(12):3440-50. PubMed ID: 16284651
[TBL] [Abstract][Full Text] [Related]
15. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
16. Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid.
Liu Z; Diaz LA; Swartz SJ; Troy JL; Fairley JA; Giudice GJ
J Immunol; 1995 Dec; 155(11):5449-54. PubMed ID: 7594563
[TBL] [Abstract][Full Text] [Related]
17. The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study.
Zhou S; Ferguson DJ; Allen J; Wojnarowska F
Br J Dermatol; 1997 Jun; 136(6):878-83. PubMed ID: 9217820
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
19. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
20. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
